-
Nexalin Technology names Carmi Masha exclusive distributor in Israel
-
FDA accepts Nexalin Q-submission for Alzheimer's treatment device
-
Nexalin receives Israeli approval for Gen 2 neurostimulation device
-
Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
Nexalin and FatPipe Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
Nexalin Technology, Inc (NXL) Prices $5.0 Million Public Offering of Common Stock
-
Nexalin (NXL) enrolls first patients in trial for Nexalin HALO
-
Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
Nexalin Technology, Inc (NXL) Files for 2.8M Share Offering by Selling Stockholders
-
Nexalin Technology (NXL) Regains Compliance with Nasdaq Continued Listing Requirements
-
LOBO EV and Nexalin Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
Nexalin Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
Nexalin Technology and VolitionRX Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
Nexalin Technology (NXL) Announces Regulatory Approval to Sell Nexalin’s Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency

